SciELO - Scientific Electronic Library Online

vol.79 número4First isolation of Escherichia coli O157:H7 from faecal and milk specimens from Anatolian water buffaloes (Bubalus bubalus) in TurkeyCanine hip extension range during gait índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



Links relacionados

  • En proceso de indezaciónCitado por Google
  • En proceso de indezaciónSimilares en Google


Journal of the South African Veterinary Association

versión On-line ISSN 2224-9435
versión impresa ISSN 1019-9128


SNYMAN, M G; NAIDOO, V; DE BRUIN, C  y  SWAN, G E. Is the current dose of a conventional oxytetracycline formulation adequate for the management of infections in sheep?. J. S. Afr. Vet. Assoc. [online]. 2008, vol.79, n.4, pp.171-174. ISSN 2224-9435.

In the veterinary industry, short-acting or conventional Oxytetracycline formulations are recommended for use once a day for 4 days, at a dose of 10 mg/kg. With the large degree of antimicrobial resistance reported, the efficacy of this dose was assessed using pharmacodynamic modelling. The specific parameters evaluated were based on the time-dependent activity of the tetracycline class of antimicrobials according to the total time above minimal inhibitory concentration (T > MIC) and the ratio of the total exposure in 24 hours, represented by area under the curve (AUC24), to the minimal inhibitory concentration (AUC24:MIC). The current pharmacokinetic study examined whether the prevailing antimicrobial resistance could be overcome by doubling the recommended conventional dose. Using reported MIC data for South Africa and elsewhere, modelling indicated the presence of a large degree of resistance. In general, doubling the dose only overcame resistance of 2 bacterial species in South Africa.

Palabras clave : conventional formulation; oxytetracycline; pharmacodynamic; pharmaco-kinetic; sheep.

        · texto en Inglés     · Inglés ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons